Growth hormone-releasing hormone analog.
Increases GH and IGF-1 levels via the GHRH receptor. Available with or without DAC for short or long half-life.
Use
Body composition. Recovery. Often combined with Ipamorelin for synergy.
Route
Subcutaneous injection. Without DAC: daily. With DAC: weekly.
Pairs with
Ipamorelin (canonical pairing). Tesamorelin.
Status
Investigational. Compounded.